Evidence map›Paper›PMID 24373354›Full record

ArticleThe Journal of allergy and clinical immunology2014

CXCR4/IgG-expressing plasma cells are associated with human gastrointestinal tissue inflammation.

Clarisa M Buckner, Susan Moir, Lela Kardava, Jason Ho, Brian H Santich, Leo Jin Young Kim, Emily K Funk, Amy K Nelson, Britanny Winckler, Cheryl L Chairez and 10 more

Registry-linked trialAbstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00325078 (Tumor Necrosis Factor Alpha Inhibitor), which is not on this map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00325078 phase1 / phase2terminatednot on this map

Tumor Necrosis Factor Alpha Inhibitor (Lnfliximab, Adalimumab) Treatment for Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease: A Phase I/II Study Assessing Clinical and Immune Responses to Treatment and Genetic Influences

TypeinterventionalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2006 to 2012Enrolled40ConditionsChronic Granulomatous Disease, Crohn'S-like IBD, Inflammatory Bowel Disease (IBD)ArmsInfliximab
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Spatial transcriptomics andFrontiers in immunology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. B-cell responses to HIV infection.Immunological reviews · 2017
    Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 2 countries.

Clarisa M BucknerLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Md.
Susan MoirLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Md. Electronic address: smoir@niaid.nih.gov.
Lela KardavaLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Md.
Jason HoLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Md.
Brian H SantichLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Md.
Leo Jin Young KimLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Md.
Emily K FunkLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Md.
Amy K NelsonLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Md.
Britanny WincklerLaboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, Bethesda, Md.
Cheryl L ChairezLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Md.
Narda L Theobald-WhitingLaboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, Bethesda, Md.
Sandra Anaya-O'BrienLaboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, Bethesda, Md.
Meghna AlimchandaniLaboratory of Pathology, National Cancer Institute, Bethesda, Md.
Martha M QuezadoLaboratory of Pathology, National Cancer Institute, Bethesda, Md.
Michael D YaoLaboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, Bethesda, Md.
Joseph A KovacsCritical Care Medicine, National Institutes of Health Clinical Center, Bethesda, Md.
Tae-Wook ChunLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Md.
Anthony S FauciLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Md.
Harry L MalechLaboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, Bethesda, Md.
Suk See De RavinLaboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, Bethesda, Md. Electronic address: sderavin@niaid.nih.gov.
National Institute of Allergy and Infectious Diseases · USCancer Institute (WIA) · INNational Institutes of Health Clinical Center · US

Funding

Role of Viral Reservoirs in the Pathogenesis of HIV DiseaseZIAAI000851 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI CHUN, TAE-WOOK · 2009 to 2025
$29.3M
Role of B Lymphocytes In HIV Infection And PathogenesisZIAAI000825 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MOIR, SUSAN · 2009 to 2025
$24.5M
Gene Therapy Basic Research to Treat Inherited Primary Immune DeficienciesZIAAI000644 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MALECH, HARRY L · 2009 to 2025
$12.1M
Development and Clinical Application of Gene and Cell therapies for Patients with Immune DeficienciesZIAAI000645 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DE RAVIN, SUK SEE · 2009 to 2025
$10.1M
Basic Research on Hematopoietic Human Stem CellsZIAAI000988 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MALECH, HARRY L · 2009 to 2019
$6.5M
Evaluation of HIV-related ComplicationsZIACL008075 · CLC · CLINICAL CENTER · PI KOVACS, JOSEPH A · 2009 to 2025
$0k
Intramural NIH HHS ZIA AI000825
6 · The paper itself

Abstract

backgroundWe previously reported abnormalities in circulating B cells in patients with chronic granulomatous disease (CGD) and those with HIV infection. Gastrointestinal complications are common to both diseases and likely involve perturbation of immune cells, including plasma cells (PCs). IgA is the most abundant immunoglobulin in the human body, with roles in protection and maintenance of intestinal homeostasis. IgA is produced primarily by PCs residing in mucosal tissues that are also thought to circulate in the blood.

objectiveWe sought to characterize and compare PCs in patients with infectious (HIV) and noninfectious (CGD and Crohn disease) diseases that have been associated with intestinal inflammation.

methodsPhenotypic and transcriptional analyses were performed on cells isolated from the blood and colon.

resultsIgA-secreting CCR10-expressing PCs predominated in the guts of healthy subjects, whereas in patients with HIV, CGD, and Crohn disease, there was a significant increase in the proportion of IgG-secreting PCs. Where intestinal inflammation was present, IgG-secreting PCs expressed reduced levels of CCR10 and increased levels of CXCR4. The intensity of CXCR4 expression correlated with the frequency of IgG-expressing PCs and the frequency of CXCR4(+)/IgG(+) PCs was associated with the severity of intestinal inflammatory disease yet distinct from PCs and plasmablasts circulating in the blood.

conclusionsThese findings suggest that regardless of the underlying disease, the presence of CXCR4(+)/IgG(+) PCs in the gut is a strong yet localized indicator of intestinal inflammation. Furthermore, our findings suggest that CXCR4(+)/IgG(+) PCs might play a role in immune cell homeostasis during inflammatory processes of the gut.

Indexed as

AdultBiopsyCrohn DiseaseFemaleGastroenteritisGranulomatous Disease, ChronicHIV InfectionsHumansImmunoglobulin GImmunoglobulin IsotypesImmunophenotypingMaleMiddle AgedMucous MembranePlasma CellsReceptors, CXCR4Immunoglobulin GImmunoglobulin IsotypesReceptors, CXCR4Receptors, Lymphocyte Hominggastrointestinal inflammationhoming receptorsinflammatory bowel diseasePlasma cellsprimary and infectious immunodeficiencies

Identifiers

PMID24373354
PMCPMC4040303
OpenAlexW2165613244

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.